Specifically, PHLDA3 mutations mainly in bladder cancer and spread throughout the pleckstrin domain, consisting of several frame-shift insertions or deletion mutations in a hotspot at position p. E82K/G/D. Here, PHLDA3 is linked to urinary bladder cancer.